Yeh Pai-Jui, Chiu Cheng-Tang, Lai Ming-Wei, Wu Ren-Chin, Chen Chien-Ming, Kuo Chia-Jung, Hsu Jun-Te, Su Ming-Yao, Lin Wei-Pin, Chen Tsung-Hsing, Le Puo-Hsien
Department of Pediatric Gastroenterology, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan, Taiwan.
Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan, Taiwan.
Gut Pathog. 2021 Aug 18;13(1):53. doi: 10.1186/s13099-021-00450-4.
To comprehensively analyze the risk factors, clinical characteristics, outcomes, and prognostic factors of Cytomegalovirus (CMV) enteritis.
This retrospective cohort study enrolled patients who had undergone pathological examinations for CMV enteritis. They were divided into CMV and non-CMV groups according to immunohistochemistry staining results. The risk factors, clinical presentations, endoscopic features, treatments, outcomes, and prognostic factors of CMV enteritis were then analyzed.
Forty-two patients (18 CMV, 24 non-CMV group) were included in the study. Major clinical presentations in the CMV group included gastrointestinal bleeding (72.2%), abdominal pain (55.6%), and fever (33.3%); ulcers (72.2%) were the most common endoscopic findings. In-hospital and overall mortality rates were 27.8% and 38.9%, respectively; and longer hospital stays and higher overall mortality rates were observed. Radiotherapy and C-reactive protein levels were prognostic factors for in-hospital mortality. The risk factors for CMV enteritis included immunocompromised status (p = 0.013), steroid use (p = 0.014), shock (p = 0.031), concurrent pneumonia (p = 0.01), antibiotic exposure (p < 0.001), radiotherapy (p = 0.027), chronic kidney disease (p = 0.041), and CMV colitis (p = 0.031).
Physicians should pay attention to the characteristics of CMV enteritis in high-risk patients to make an early diagnosis and potentially improve the clinical outcome.
全面分析巨细胞病毒(CMV)肠炎的危险因素、临床特征、结局及预后因素。
本回顾性队列研究纳入了接受CMV肠炎病理检查的患者。根据免疫组化染色结果将他们分为CMV组和非CMV组。然后分析CMV肠炎的危险因素、临床表现、内镜特征、治疗、结局及预后因素。
本研究共纳入42例患者(CMV组18例,非CMV组24例)。CMV组的主要临床表现包括消化道出血(72.2%)、腹痛(55.6%)和发热(33.3%);溃疡(72.2%)是最常见的内镜检查发现。住院死亡率和总死亡率分别为27.8%和38.9%;观察到住院时间更长和总死亡率更高。放疗和C反应蛋白水平是住院死亡率的预后因素。CMV肠炎的危险因素包括免疫功能低下状态(p = 0.013)、使用类固醇(p = 0.014)、休克(p = 0.031)、并发肺炎(p = 0.01)、接触抗生素(p < 0.001)、放疗(p = 0.027)、慢性肾脏病(p = 0.041)和CMV结肠炎(p = 0.031)。
医生应关注高危患者CMV肠炎的特征,以便早期诊断并可能改善临床结局。